• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

编码利什曼原虫感染因子(LeIF)基因和白细胞介素-12(IL-12)的DNA疫苗共递送可增强BALB/c小鼠对硕大利什曼原虫感染的抵抗力。

Codelivery of DNA vaccination encoding LeIF gene and IL-12 increases protection against Leishmania major infection in BALB/c mice.

作者信息

Maspi N, Ghaffarifar F, Sharifi Z, Dalimi A

机构信息

Department of Medical Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.

出版信息

Parasite Immunol. 2016 Apr;38(4):228-35. doi: 10.1111/pim.12310.

DOI:10.1111/pim.12310
PMID:26868280
Abstract

Previous studies have shown that Leishmania elongation initiation factor (LeIF) antigen causes a partial immunity against leishmaniasis. The antigen develops type I immunity by overexpression of inflammatory cytokines such as interleukin-12 (IL-12), IFN-γ and TNF-α. Therefore, We evaluated immune responses induced by the LeIF gene against Leishmania major infection. Immunization with LeIF gene alone or with IL-12 induced Th1 response and produced higher IFN-γ and lower IL-4 levels by splenocytes than control groups (P < 0·05) and also ratios of IFN-γ/IL-4 were 11·68 to 18·53 times more in immunized groups than control groups after challenge. In addition, analysis of humoral immune response revealed that immunized mice had more IgG2a levels than both control groups (P < 0·05). On the other hand, lesion size was less for immunized animals than control groups from 4th week after challenge (P < 0·05). The percentage reduction in lesion size was 29·30% for LeIF and 51·98% for LeIF + IL-12 than PBS at 12th week post-infection. Spleen parasite burden decreased in all immunized groups in comparison with control groups (P < 0·05). The results indicated that LeIF gene induced partial immunity against L. major infection in BALB/c mice. However, LeIF plus IL-12 group showed more potent immunity with smaller lesions than other groups.

摘要

先前的研究表明,利什曼原虫延伸起始因子(LeIF)抗原可引起对利什曼病的部分免疫力。该抗原通过白细胞介素-12(IL-12)、干扰素-γ(IFN-γ)和肿瘤坏死因子-α等炎性细胞因子的过表达产生I型免疫。因此,我们评估了LeIF基因针对硕大利什曼原虫感染诱导的免疫反应。单独用LeIF基因或与IL-12一起免疫诱导了Th1反应,与对照组相比,脾细胞产生的IFN-γ水平更高,IL-4水平更低(P<0.05),并且攻击后免疫组中IFN-γ/IL-4的比率比对照组高11.68至18.53倍。此外,体液免疫反应分析显示,免疫小鼠的IgG2a水平高于两个对照组(P<0.05)。另一方面,从攻击后第4周起,免疫动物的病变大小比对照组小(P<0.05)。在感染后第12周,与PBS相比,LeIF组的病变大小减少百分比为29.30%,LeIF+IL-12组为51.98%。与对照组相比,所有免疫组的脾脏寄生虫负荷均降低(P<0.05)。结果表明,LeIF基因在BALB/c小鼠中诱导了针对硕大利什曼原虫感染的部分免疫力。然而,LeIF加IL-12组显示出比其他组更强的免疫力,病变更小。

相似文献

1
Codelivery of DNA vaccination encoding LeIF gene and IL-12 increases protection against Leishmania major infection in BALB/c mice.编码利什曼原虫感染因子(LeIF)基因和白细胞介素-12(IL-12)的DNA疫苗共递送可增强BALB/c小鼠对硕大利什曼原虫感染的抵抗力。
Parasite Immunol. 2016 Apr;38(4):228-35. doi: 10.1111/pim.12310.
2
Comparative Assessment of Induced Immune Responses Following Intramuscular Immunization with Fusion and Cocktail of LeIF, LACK and TSA Genes Against Cutaneous Leishmaniasis in BALB/c Mice.肌肉内免疫接种 LeIF、LACK 和 TSA 基因融合和鸡尾酒对 BALB/c 小鼠皮肤利什曼病诱导免疫反应的比较评估。
Arch Immunol Ther Exp (Warsz). 2018 Feb;66(1):55-64. doi: 10.1007/s00005-017-0484-4. Epub 2017 Aug 4.
3
LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.LeIF:一种可诱导白细胞介素-12介导的辅助性T细胞1型细胞因子谱的重组利什曼原虫蛋白。
J Immunol. 1998 Dec 1;161(11):6171-9.
4
Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.用编码利什曼原虫核小体组蛋白的质粒DNA混合物进行疫苗接种可提供针对小鼠皮肤利什曼病的保护作用。
Vaccine. 2004 Sep 28;22(29-30):3865-76. doi: 10.1016/j.vaccine.2004.04.015.
5
Immunogenicity and efficacy of a bivalent DNA vaccine containing LeIF and TSA genes against murine cutaneous leishmaniasis.一种含LeIF和TSA基因的二价DNA疫苗对小鼠皮肤利什曼病的免疫原性和疗效
APMIS. 2017 Mar;125(3):249-258. doi: 10.1111/apm.12651.
6
Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis.评价 LPG3 对易感 BALB/c 小鼠感染利什曼原虫的 DNA/DNA 和初免-加强免疫接种及其在人类利什曼病中的抗原性。
Exp Parasitol. 2011 Mar;127(3):627-36. doi: 10.1016/j.exppara.2010.12.007. Epub 2010 Dec 25.
7
Effect of IL-22 on DNA vaccine encoding LACK gene of Leishmania major in BALB/c mice.白细胞介素 22 对编码利什曼原虫大囊蛋白基因 DNA 疫苗的影响。
Exp Parasitol. 2013 Jul;134(3):341-8. doi: 10.1016/j.exppara.2013.03.012. Epub 2013 Mar 27.
8
A single intradermal administration of soluble leishmanial antigen and plasmid expressing interleukin-12 protects BALB/c mice from Leishmania major infection.单次皮内注射可溶性利什曼原虫抗原和表达白细胞介素-12的质粒可保护BALB/c小鼠免受硕大利什曼原虫感染。
Parasitol Int. 2001 Jul;50(2):81-91. doi: 10.1016/s1383-5769(01)00070-8.
9
Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major.用编码免疫显性LACK寄生虫抗原的DNA进行疫苗接种可使感染硕大利什曼原虫的小鼠获得保护性免疫。
J Exp Med. 1997 Oct 6;186(7):1137-47. doi: 10.1084/jem.186.7.1137.
10
Evaluation of Leishmanization Using Mixed With CpG-ODN as a Candidate Vaccine Against Experimental Murine Leishmaniasis.评价混合 CpG-ODN 的利什曼化作为实验性抗小鼠利什曼病候选疫苗。
Front Immunol. 2020 Oct 23;11:1725. doi: 10.3389/fimmu.2020.01725. eCollection 2020.

引用本文的文献

1
The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics.先天免疫系统在 mRNA 治疗有效性中的双重作用。
Int J Mol Sci. 2023 Oct 1;24(19):14820. doi: 10.3390/ijms241914820.
2
Design, Construction and Immunogenicity Assessment of pEGFP-N1-KMP11-GP96 (Fusion) as a DNA Vaccine Candidate against Infection in BALB/c Mice.pEGFP-N1-KMP11-GP96(融合体)作为抗BALB/c小鼠感染的DNA疫苗候选物的设计、构建及免疫原性评估
Iran J Parasitol. 2020 Jan-Mar;15(1):11-21.
3
Cloning and molecular characterization of thiol-specific antioxidant gene of Leishmania tropica Turkey isolate.
土耳其利什曼原虫分离株硫醇特异性抗氧化基因的克隆和分子特征。
Turk J Med Sci. 2019 Feb 11;49(1):392-402. doi: 10.3906/sag-1808-98.
4
Cutaneous Leishmaniasis: Update on Vaccine Development.皮肤利什曼病:疫苗研发进展
Hum Parasit Dis (Auckl). 2017;9. doi: 10.4137/HPD.S16588.
5
Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.皮肤利什曼病中的促炎和抗炎细胞因子:综述
Pathog Glob Health. 2016 Sep;110(6):247-260. doi: 10.1080/20477724.2016.1232042. Epub 2016 Sep 23.